Sept 6 (Reuters) - Progenics Pharmaceuticals Inc PGNX.O
* Valeant and Progenics announce the U.S. commercial launch of FDA approved Relistor tablets Source text for Eikon: ID:nCNWbQ24pa Further company coverage: PGNX.O
Sept 6 (Reuters) - Progenics Pharmaceuticals Inc PGNX.O
* Valeant and Progenics announce the U.S. commercial launch of FDA approved Relistor tablets Source text for Eikon: ID:nCNWbQ24pa Further company coverage: PGNX.O